FI20010154A - Process for the preparation of citalopram - Google Patents
Process for the preparation of citalopram Download PDFInfo
- Publication number
- FI20010154A FI20010154A FI20010154A FI20010154A FI20010154A FI 20010154 A FI20010154 A FI 20010154A FI 20010154 A FI20010154 A FI 20010154A FI 20010154 A FI20010154 A FI 20010154A FI 20010154 A FI20010154 A FI 20010154A
- Authority
- FI
- Finland
- Prior art keywords
- citalopram
- preparation
- Prior art date
Links
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 title 1
- 229960001653 citalopram Drugs 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
- B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
- B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/847—Nickel
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199900921 | 1999-06-25 | ||
| DK92199 | 1999-06-25 | ||
| DK9900643 | 1999-11-19 | ||
| PCT/DK1999/000643 WO2000011926A2 (en) | 1999-06-25 | 1999-11-19 | Method for the preparation of citalopram |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20010154A true FI20010154A (en) | 2001-02-09 |
| FI108538B FI108538B (en) | 2002-02-15 |
Family
ID=8099044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20010154A FI108538B (en) | 1999-06-25 | 2001-01-25 | Process for the preparation of citalopram |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6750358B2 (en) |
| EP (1) | EP1105382B1 (en) |
| JP (1) | JP3389571B2 (en) |
| KR (1) | KR100491369B1 (en) |
| CN (1) | CN1129593C (en) |
| AR (1) | AR020573A1 (en) |
| AT (3) | ATE213237T1 (en) |
| AU (2) | AU2001100433B4 (en) |
| BG (1) | BG106190A (en) |
| BR (1) | BR9917367A (en) |
| CA (1) | CA2290125C (en) |
| CH (1) | CH691304A5 (en) |
| CZ (1) | CZ292174B6 (en) |
| DE (2) | DE19983486C2 (en) |
| DK (1) | DK1105382T3 (en) |
| EA (1) | EA002661B1 (en) |
| ES (1) | ES2172356T3 (en) |
| FI (1) | FI108538B (en) |
| GB (1) | GB2354240B (en) |
| HK (1) | HK1047745B (en) |
| HU (1) | HUP0103417A3 (en) |
| IL (1) | IL145960A0 (en) |
| IS (1) | IS5862A (en) |
| IT (1) | ITMI991579A1 (en) |
| MX (1) | MXPA01010986A (en) |
| NO (1) | NO20010318L (en) |
| NZ (1) | NZ514982A (en) |
| PL (1) | PL345971A1 (en) |
| PT (1) | PT1105382E (en) |
| SE (1) | SE516689C2 (en) |
| SI (1) | SI1105382T1 (en) |
| SK (1) | SK18412001A3 (en) |
| TR (1) | TR200103700T2 (en) |
| UA (1) | UA62023C2 (en) |
| WO (1) | WO2000011926A2 (en) |
| ZA (1) | ZA200108855B (en) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2356188C (en) | 1998-12-23 | 2006-05-23 | H. Lundbeck A/S | Method for the preparation of 5-cyanophthalide |
| AR022329A1 (en) | 1999-01-29 | 2002-09-04 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF 5-CYANOFTALIDE |
| TR200102957T2 (en) | 1999-04-14 | 2004-12-21 | H. Lundbeck A/S | Method for the preparation of citalopram. |
| ITMI991581A1 (en) * | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF CITALOPRAM |
| ITMI991579A1 (en) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF CITALOPRAM |
| DK1298124T3 (en) | 1999-10-25 | 2007-07-09 | Lundbeck & Co As H | Process for the preparation of citalopram |
| ES2169709A1 (en) | 1999-10-25 | 2002-07-01 | Lundbeck & Co As H | Method for the preparation of citalopram |
| AR026063A1 (en) | 1999-11-01 | 2002-12-26 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF 5-CARBOXIFTALIDA. |
| SI1246812T1 (en) | 1999-12-28 | 2004-08-31 | H. Lundbeck A/S | Method for the preparation of citalopram |
| PT1246813E (en) | 1999-12-30 | 2004-02-27 | Lundbeck & Co As H | METHOD FOR PREPARING CITALOPRAM |
| EA005134B1 (en) | 2000-01-14 | 2004-12-30 | Х.Лундбекк А/С | Method for the preparation of 5-cyanophthalide |
| FR2805812A1 (en) | 2000-02-24 | 2001-09-07 | Lundbeck & Co As H | PROCESS FOR THE PREPARATION OF CITALOPRAM |
| IES20010157A2 (en) | 2000-03-03 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
| NZ521201A (en) | 2000-03-13 | 2004-02-27 | H | Method for the preparation of citalopram |
| IES20010206A2 (en) | 2000-03-13 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| CN1427835A (en) * | 2000-03-13 | 2003-07-02 | H·隆德贝克有限公司 | Stepwise Alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| GB2357762B (en) | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
| ATE257832T1 (en) | 2000-03-14 | 2004-01-15 | Lundbeck & Co As H | METHOD FOR PRODUCING CITALOPRAM |
| WO2001068632A1 (en) * | 2000-03-16 | 2001-09-20 | H. Lundbeck A/S | Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| AR032455A1 (en) | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF CITALOPRAM, AN INTERMEDIARY EMPLOYED IN THE METHOD, A METHOD FOR THE PREPARATION OF THE INTERMEDIARY EMPLOYED IN THE METHOD AND PHARMACEUTICAL COMPOSITION ANTIDEPRESSIVE |
| WO2002004435A1 (en) * | 2000-07-06 | 2002-01-17 | H. Lundbeck A/S | Method for the preparation of citalopram |
| IL144817A0 (en) * | 2000-08-18 | 2002-06-30 | Lundbeck & Co As H | Method for the preparation of citalopram |
| EP1181713B1 (en) | 2000-12-22 | 2004-09-29 | H. Lundbeck A/S | Method for the preparation of pure citalopram |
| PT1181272E (en) | 2000-12-28 | 2003-01-31 | Lundbeck & Co As H | PROCESS FOR THE PREPARATION OF PURE CITALOPRAM |
| WO2002060886A1 (en) | 2001-01-30 | 2002-08-08 | Orion Corporation, Fermion | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile |
| HUP0400095A3 (en) * | 2001-03-09 | 2005-10-28 | Ranbaxy Lab Ltd | Process for the preparation of citalopram |
| ES2280892T3 (en) | 2001-07-31 | 2007-09-16 | H. Lundbeck A/S | CRYSTAL COMPOSITION CONTAINING ESCITALOPRAM. |
| WO2003057132A2 (en) | 2002-01-07 | 2003-07-17 | Sun Pharmaceutical Industries Limited | Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile |
| TWI306846B (en) | 2002-08-12 | 2009-03-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| US20050154052A1 (en) * | 2003-03-24 | 2005-07-14 | Hetero Drugs Limited | Novel crystalline forms of (s)-citalopram oxalate |
| EP1486492A3 (en) * | 2003-06-10 | 2005-02-23 | Sun Pharmaceuticals Industries Ltd. | A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran. |
| TWI339651B (en) | 2004-02-12 | 2011-04-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| JP2006008603A (en) * | 2004-06-25 | 2006-01-12 | Sumitomo Chemical Co Ltd | Method for producing optically active citalopram, its intermediate and method for producing the same |
| WO2006021971A2 (en) | 2004-08-23 | 2006-03-02 | Sun Pharmaceutical Industries Limited | 'process for preparation of citalopram and enantiomers' |
| WO2006103550A1 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Processes for the preparation of citalopram and its intermediate 5-aminophthalide |
| US7834201B2 (en) | 2005-06-22 | 2010-11-16 | H. Lundbeck A/S | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| TWI347942B (en) | 2005-06-22 | 2011-09-01 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| EP2017271A1 (en) | 2007-07-06 | 2009-01-21 | Aurobindo Pharma Limited | Process for the preparation of escitalopram |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143702A (en) | 1965-03-18 | |||
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| GB8419963D0 (en) | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
| GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| CA2010159A1 (en) | 1989-02-21 | 1990-08-21 | James J. Maul | Cyanation of haloaromatics utilizing catalysts generated in situ starting with nic1 or nic1 6h 0 |
| US5296507A (en) | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
| DE19626659A1 (en) | 1996-07-03 | 1998-01-08 | Basf Ag | Process for the production of phthalides |
| DE19627697A1 (en) | 1996-07-10 | 1998-01-15 | Basf Ag | Process for the production of phthalides |
| DE19706648A1 (en) | 1997-02-20 | 1998-08-27 | Bayer Ag | Process for the production of aromatic nitriles |
| PT1015416E (en) | 1997-07-08 | 2002-03-28 | Lundbeck & Co As H | METHOD FOR THE PRODUCTION OF CITALOPRAM |
| UA62985C2 (en) | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
| AU738359B2 (en) | 1997-11-11 | 2001-09-13 | H. Lundbeck A/S | Method for the preparation of citalopram |
| HU228576B1 (en) | 1998-10-20 | 2013-04-29 | Lundbeck & Co As H | Method for the preparation of citalopram |
| CA2356188C (en) | 1998-12-23 | 2006-05-23 | H. Lundbeck A/S | Method for the preparation of 5-cyanophthalide |
| AR022329A1 (en) | 1999-01-29 | 2002-09-04 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF 5-CYANOFTALIDE |
| DE10015280A1 (en) | 1999-03-29 | 2001-01-04 | Nissan Chemical Ind Ltd | Substituted benzonitrile derivative preparation in high yield, for use as herbicide or intermediate, from halo compound and sodium, potassium or zinc cyanide in presence of metal catalyst |
| TR200102957T2 (en) | 1999-04-14 | 2004-12-21 | H. Lundbeck A/S | Method for the preparation of citalopram. |
| ITMI991579A1 (en) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF CITALOPRAM |
| ITMI991581A1 (en) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | METHOD FOR THE PREPARATION OF CITALOPRAM |
| ES2169709A1 (en) | 1999-10-25 | 2002-07-01 | Lundbeck & Co As H | Method for the preparation of citalopram |
| US6310222B1 (en) | 1999-11-01 | 2001-10-30 | Sumika Fine Chemicals Co., Ltd. | Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
| GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
| EP1181713B1 (en) | 2000-12-22 | 2004-09-29 | H. Lundbeck A/S | Method for the preparation of pure citalopram |
| PT1181272E (en) | 2000-12-28 | 2003-01-31 | Lundbeck & Co As H | PROCESS FOR THE PREPARATION OF PURE CITALOPRAM |
-
1999
- 1999-07-15 IT IT1999MI001579A patent/ITMI991579A1/en unknown
- 1999-11-19 ES ES99968206T patent/ES2172356T3/en not_active Expired - Lifetime
- 1999-11-19 UA UA2001117897A patent/UA62023C2/en unknown
- 1999-11-19 HU HU0103417A patent/HUP0103417A3/en unknown
- 1999-11-19 DE DE19983486T patent/DE19983486C2/en not_active Expired - Fee Related
- 1999-11-19 KR KR10-2001-7013971A patent/KR100491369B1/en not_active IP Right Cessation
- 1999-11-19 CH CH00307/01A patent/CH691304A5/en not_active IP Right Cessation
- 1999-11-19 SK SK1841-2001A patent/SK18412001A3/en unknown
- 1999-11-19 PL PL99345971A patent/PL345971A1/en not_active Application Discontinuation
- 1999-11-19 PT PT99968206T patent/PT1105382E/en unknown
- 1999-11-19 MX MXPA01010986A patent/MXPA01010986A/en not_active IP Right Cessation
- 1999-11-19 SI SI9930039T patent/SI1105382T1/en unknown
- 1999-11-19 AU AU2001100433A patent/AU2001100433B4/en not_active Ceased
- 1999-11-19 DE DE69900891T patent/DE69900891D1/en not_active Expired - Lifetime
- 1999-11-19 DK DK99968206T patent/DK1105382T3/en active
- 1999-11-19 EA EA200101071A patent/EA002661B1/en not_active IP Right Cessation
- 1999-11-19 CN CN99816768A patent/CN1129593C/en not_active Expired - Fee Related
- 1999-11-19 AT AT99968206T patent/ATE213237T1/en not_active IP Right Cessation
- 1999-11-19 IL IL14596099A patent/IL145960A0/en unknown
- 1999-11-19 EP EP99968206A patent/EP1105382B1/en not_active Expired - Lifetime
- 1999-11-19 NZ NZ514982A patent/NZ514982A/en unknown
- 1999-11-19 JP JP2000567065A patent/JP3389571B2/en not_active Expired - Fee Related
- 1999-11-19 TR TR2001/03700T patent/TR200103700T2/en unknown
- 1999-11-19 AT AT0904099A patent/AT409960B/en not_active IP Right Cessation
- 1999-11-19 GB GB0101508A patent/GB2354240B/en not_active Expired - Fee Related
- 1999-11-19 AU AU13748/00A patent/AU1374800A/en active Pending
- 1999-11-19 CZ CZ2001319A patent/CZ292174B6/en not_active IP Right Cessation
- 1999-11-19 WO PCT/DK1999/000643 patent/WO2000011926A2/en active IP Right Grant
- 1999-11-19 BR BR9917367-0A patent/BR9917367A/en not_active IP Right Cessation
- 1999-11-22 CA CA002290125A patent/CA2290125C/en not_active Expired - Fee Related
-
2000
- 2000-06-21 AR ARP000103080A patent/AR020573A1/en unknown
-
2001
- 2001-01-19 NO NO20010318A patent/NO20010318L/en unknown
- 2001-01-24 SE SE0100194A patent/SE516689C2/en not_active IP Right Cessation
- 2001-01-25 FI FI20010154A patent/FI108538B/en not_active IP Right Cessation
- 2001-02-23 IS IS5862A patent/IS5862A/en unknown
- 2001-03-13 AT AT0018501U patent/AT4366U1/en not_active IP Right Cessation
- 2001-10-26 ZA ZA200108855A patent/ZA200108855B/en unknown
- 2001-11-06 US US10/012,025 patent/US6750358B2/en not_active Expired - Fee Related
- 2001-12-07 BG BG106190A patent/BG106190A/en unknown
-
2002
- 2002-12-24 HK HK02109330.8A patent/HK1047745B/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20010154A (en) | Process for the preparation of citalopram | |
| NO20015017L (en) | Process for the preparation of citalopram | |
| NO20010319L (en) | Process for the preparation of Citalopram | |
| NO20011936D0 (en) | Process for the preparation of Citalopram | |
| NO20013185L (en) | Process for the preparation of citalopram | |
| FI20011578A0 (en) | Process for the preparation of pure citalopram | |
| FI20011621A (en) | Process for the preparation of citalopram | |
| NO20030012L (en) | Process for the preparation of substituted octanoylamides | |
| NO20013667D0 (en) | Process for the preparation of 5-cyanophthalide | |
| NO20040027L (en) | Process for the preparation of escitalopram | |
| NO20025423L (en) | Process for the preparation of Citalopram | |
| NO20003454L (en) | Process for the preparation of (-) cis-3-hydroxy-1-methyl-4- | |
| NO20021118D0 (en) | Process for the preparation of citalopram | |
| DK1228056T3 (en) | Process for the preparation of citalopram | |
| NO20030515D0 (en) | Process for the preparation of dinapsoline | |
| NO20013995L (en) | Process for the preparation of L-sorbose | |
| NO20020328D0 (en) | Process for the preparation of 4-cyano-2-aminomethylthiazole | |
| NO20020327D0 (en) | Process for the preparation of 2-aminomethyl-4-cyano-thiazole | |
| NO20023702L (en) | Process for the preparation of 5-arylnicotinaldehydes | |
| FI20070687A (en) | Process for the preparation of citalopram | |
| FI991618A (en) | Process for the preparation of pulp | |
| EE200200053A (en) | Process of preparation of isoretinoin | |
| TH34294B (en) | Process for the preparation of chlorobexosazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |